Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.12 0.91 (4.33%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.67(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 60,000
Total Buy Value $0 $0 $0 $980,094
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 20,000 20,000 104,169 535,146
Total Sell Value $460,127 $460,127 $2,968,197 $14,025,264
Total People Sold 2 2 4 8
Total Sell Transactions 2 2 12 30
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 524
  Page 8 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-02-26 4 A $0.00 $0 D/D 20,000 184,268     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-02-26 4 A $0.00 $0 D/D 12,500 80,764     -
   Kennedy Keith COO / CFO   •       –      –    2021-02-26 4 A $0.00 $0 D/D 15,000 122,641     -
   Erlinger Iii James H EVP, General Counsel   –       –      –    2021-02-26 4 A $0.00 $0 D/D 7,500 7,500     -
   Eastham Karin Director   –       •      –    2021-02-25 4 AS $60.03 $379,359 D/D (6,250) 0 -35%     
   Eastham Karin Director   –       •      –    2021-02-25 4 OE $4.00 $25,000 D/D 6,250 6,250     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-02-24 4 D $62.30 $2,460,102 D/D (39,488) 164,268     -
   Kennedy Keith COO / CFO   •       –      –    2021-02-24 4 D $62.30 $688,166 D/D (11,046) 107,641     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-02-24 4 D $62.30 $625,990 D/D (10,048) 68,264     -
   Jones Evan/ Fa Director   –       •      –    2021-01-22 4 OE $2.36 $11,800 D/D 5,000 30,000     -
   Ho Mark Principal Accounting Officer   •       •      –    2021-01-20 4 OE $4.94 $270,675 D/D 52,500 71,434     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-13 4 AS $50.64 $946,462 D/D (18,541) 203,756 -23%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-13 4 OE $5.61 $104,015 D/D 18,541 222,297     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-12 4 AS $49.77 $1,021,772 D/D (20,354) 203,756 -24%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-12 4 OE $5.61 $114,186 D/D 20,354 224,110     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-11 4 AS $49.81 $3,599,303 D/D (71,105) 203,756 -26%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-11 4 OE $5.61 $610,741 D/D 71,105 274,861     -
   Gordon Kevin K Director   •       •      –    2021-01-04 4 AS $48.62 $489,798 D/D (10,000) 0 -26%     
   Gordon Kevin K Director   •       •      –    2021-01-04 4 OE $7.39 $73,900 D/D 10,000 10,000     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-12-29 4 OE $2.68 $116,919 D/D 31,313 203,756     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-04 4 AS $55.78 $797,156 D/D (14,015) 78,312 -16%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-04 4 OE $5.98 $150,209 D/D 13,468 92,327     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-02 4 D $55.08 $29,743 D/D (540) 78,859     -
   Gordon Kevin K Director   •       •      –    2020-11-12 4 AS $46.95 $471,138 D/D (10,000) 0 8%     
   Gordon Kevin K Director   •       •      –    2020-11-12 4 OE $7.39 $73,900 D/D 10,000 10,000     -
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us